PubMed

Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients.

Shafer RW, Winters MA, Palmer S, Merigan TC.

Ann Intern Med. 1998 Jun 1;128(11):906-11.PMID: 9634429 [PubMed - indexed for MEDLINE]Related articlesFree article

Analysis of HIV drug-resistant quasispecies in plasma, peripheral blood mononuclear cells and viral isolates from treatment-naive and HAART patients.

Paolucci S, Baldanti F, Campanini G, Zavattoni M, Cattaneo E, Dossena L, Gerna G.

J Med Virol. 2001 Oct;65(2):207-17.PMID: 11536225 [PubMed - indexed for MEDLINE]Related articles

HIV-1 reverse transcriptase and protease resistance mutations selected during 16-72 weeks of therapy in isolates from antiretroviral therapy-experienced patients receiving abacavir/efavirenz/amprenavir in the CNA2007 study.

Ait-Khaled M, Rakik A, Griffin P, Stone C, Richards N, Thomas D, Falloon J, Tisdale M; CNA2007 International Study Team.

Antivir Ther. 2003 Apr;8(2):111-20.PMID: 12741623 [PubMed - indexed for MEDLINE]Related articles

Comparison of DNA sequencing and a line probe assay for detection of human immunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy.

Servais J, Lambert C, Fontaine E, Plesséria JM, Robert I, Arendt V, Staub T, Schneider F, Hemmer R, Burtonboy G, Schmit JC.

J Clin Microbiol. 2001 Feb;39(2):454-9.PMID: 11158089 [PubMed - indexed for MEDLINE]Related articlesFree article

Mutations in HIV-1 reverse transcriptase during therapy with abacavir, lamivudine and zidovudine in HIV-1-infected adults with no prior antiretroviral therapy.

Ait-Khaled M, Rakik A, Griffin P, Cutrell A, Fischl MA, Clumeck N, Greenberg SB, Rubio R, Peters BS, Pulido F, Gould J, Pearce G, Spreen W, Tisdale M, Lafon S; CNA3003 International Study Team.

Antivir Ther. 2002 Mar;7(1):43-51.PMID: 12008787 [PubMed - indexed for MEDLINE]Related articles

Quantification of the impact of HIV-1 reverse transcriptase and protease mutations on the efficacy of rescue HAART.

Paolucci S, Baldanti F, Maserati R, Castelli F, Suter F, Maggiolo F, Pan A, Gerna G.

Antiviral Res. 2000 Feb;45(2):101-14.PMID: 10809019 [PubMed - indexed for MEDLINE]Related articles

Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy. STADI Group.

Pellegrin I, Izopet J, Reynes J, Denayrolles M, Montes B, Pellegrin JL, Massip P, Puel J, Fleury H, Segondy M.

AIDS. 1999 Sep 10;13(13):1705-9.PMID: 10509572 [PubMed - indexed for MEDLINE]Related articles

Clinical cross-resistance between the HIV-1 protease inhibitors saquinavir and indinavir and correlations with genotypic mutations.

Schapiro JM, Winters MA, Lawrence J, Merigan TC.

AIDS. 1999 Feb 25;13(3):359-65.PMID: 10199226 [PubMed - indexed for MEDLINE]Related articles

HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.

Hermankova M, Ray SC, Ruff C, Powell-Davis M, Ingersoll R, D'Aquila RT, Quinn TC, Siliciano JD, Siliciano RF, Persaud D.

JAMA. 2001 Jul 11;286(2):196-207.PMID: 11448283 [PubMed - indexed for MEDLINE]Related articlesFree article

Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine.

Coakley EP, Gillis JM, Hammer SM.

AIDS. 2000 Jan 28;14(2):F9-15.PMID: 10708277 [PubMed - indexed for MEDLINE]Related articles

Low-rate emergence of thymidine analogue mutations and multi-drug resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus lamivudine combination therapy.

Mouroux M, Descamps D, Izopet J, Yvon A, Delaugerre C, Matheron S, Coutellier A, Valantin MA, Bonmarchand M, Agut H, Massip P, Costagliola D, Katlama C, Brun-Vezinet F, Calvez V.

Antivir Ther. 2001 Sep;6(3):179-83.PMID: 11808752 [PubMed - indexed for MEDLINE]Related articles

Drug-resistant reverse transcriptase genotyping and phenotyping of B and non-B subtypes (F and A) of human immunodeficiency virus type I found in Brazilian patients failing HAART.

Caride E, Brindeiro R, Hertogs K, Larder B, Dehertogh P, Machado E, de Sá CA, Eyer-Silva WA, Sion FS, Passioni LF, Menezes JA, Calazans AR, Tanuri A.

Virology. 2000 Sep 15;275(1):107-15.PMID: 11017792 [PubMed - indexed for MEDLINE]Related articles

Phenotypic and genotypic resistance to nucleoside reverse transcriptase inhibitors in HIV-1 clinical isolates.

Lafeuillade A, Poggi C, Hittinger G, Chadapaud S.

HIV Med. 2001 Oct;2(4):231-5.PMID: 11737402 [PubMed - indexed for MEDLINE]Related articles

N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance.

Yap SH, Sheen CW, Fahey J, Zanin M, Tyssen D, Lima VD, Wynhoven B, Kuiper M, Sluis-Cremer N, Harrigan PR, Tachedjian G.

PLoS Med. 2007 Dec;4(12):e335.PMID: 18052601 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.

Gómez-Cano M, Rubio A, Puig T, Pérez-Olmeda M, Ruiz L, Soriano V, Pineda JA, Zamora L, Xaus N, Clotet B, Leal M.

AIDS. 1998 Jun 18;12(9):1015-20.PMID: 9662197 [PubMed - indexed for MEDLINE]Related articles

High-level resistance to zidovudine but not to zalcitabine or didanosine in human immunodeficiency virus from children receiving antiretroviral therapy.

Husson RN, Shirasaka T, Butler KM, Pizzo PA, Mitsuya H.

J Pediatr. 1993 Jul;123(1):9-16.PMID: 8391570 [PubMed - indexed for MEDLINE]Related articles

Thymidine analog and multinucleoside resistance mutations are associated with decreased phenotypic susceptibility to stavudine in HIV type 1 isolated from zidovudine-naive patients experiencing viremia on stavudine-containing regimens.

Ross L, Scarsella A, Raffanti S, Henry K, Becker S, Fisher R, Liao Q, Hirani A, Graham N, St Clair M, Hernandez J; NZT40012 Study Team.

AIDS Res Hum Retroviruses. 2001 Aug 10;17(12):1107-15.PMID: 11522180 [PubMed - indexed for MEDLINE]Related articles

Mutation patterns of the reverse transcriptase genes in HIV-1 infected patients receiving combinations of nucleoside and non nucleoside inhibitors.

Re MC, Bon I, Monari P, Borderi M, Gibellini D, Schiavone P, Vitone F, Chiodo F, La Placa M.

Int J Antimicrob Agents. 2003 Oct;22(4):388-94.PMID: 14522102 [PubMed - indexed for MEDLINE]Related articles

Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure.

Miller V, Larder BA.

Antivir Ther. 2001;6 Suppl 3:25-44. Review.PMID: 11678471 [PubMed - indexed for MEDLINE]Related articles

Reduced antiretroviral drug susceptibility among patients with primary HIV infection.

Little SJ, Daar ES, D'Aquila RT, Keiser PH, Connick E, Whitcomb JM, Hellmann NS, Petropoulos CJ, Sutton L, Pitt JA, Rosenberg ES, Koup RA, Walker BD, Richman DD.

JAMA. 1999 Sep 22-29;282(12):1142-9.PMID: 10501117 [PubMed - indexed for MEDLINE]Related articlesFree article